Skip to main content

Table 1 Serologic testing in patients sent for duodenal biopsy

From: Limited utilization of serologic testing in patients undergoing duodenal biopsy for celiac disease

  

Biopsy result

 

N

Celiac

IVA

Other

NEG

No serology prior to biopsy

977

1.6%

6.2%

7.6%

84.5%

Pre-biopsy serology

     

Positive serology

68

35.3%

10.3%

2.9%

51.5%

Negative serology

387

1.0%

4.4%

8.3%

95.3%

  1. N = total number of biopsies in each serologic category. Biopsy results refer only to findings from the duodenal biopsy. IVA = intact villous architecture with intra-epithelial lymphocytes. Findings consistent with celiac disease were significantly higher in patients with positive pre-biopsy serologic results when compared to either group (p < 0.001, Fisher’s exact test).